| Market Cap | ₹150Cr |
| ROE | 18.42% |
| P/E Ratio(TTM) | -5.53 |
| EPS(TTM) | -12.57 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.00 |
| Book Value | -67.83 |
| Debt to Equity | -1.45 |
| Face Value | 10 |
| Parent Organisation | Krebs Biochemicals And Industries |
| Managing Director | Mr. Pabitra Bhattacharya |
| NSE Symbol | KREBSBIO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 74.94 | ||
| Neuland Laboratories | NA (0.00%) | 111.98 | ||
| Jubilant Pharmova | NA (0.00%) | 39.60 | ||
| Acutaas Chemicals | NA (0.00%) | 61.29 |